Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Craig Collard Insider Profile
4 Followers
Craig Collard, Chief Executive Officer, Director at Cornerstone Therapeutics Inc, holds 290.39K shares in Heron Therapeutics (Ticker: HRTX), holds 0.00 shares in Opiant Pharmaceuticals (Ticker: OPNT), holds 0.00 shares in Sierra Oncology (Ticker: SRRA).
Craig Collard Cornerstone Therapeutics Inc (~CRTX)Chief Executive Officer, Director
Cornerstone Therapeutics Inc (~CRTX)
Chief Executive Officer, Director
Ranked #59,550 out of 99,218 Corporate Insiders
Profitable Transactions
1 out of 3 Profitable Transactions
Average Return
-8.00%
Average return per transaction
Time Frame
Compare to
Insider Roles
CEO, Director
Roles that Craig Collard holds in companies
Most Profitable Insider Trade
The most profitable trade made by Craig Collard
Craig Collard's Trading History
Cornerstone Therapeutics Inc
Feb 04, 2014
―
Uninformative Sell
14.89M
―
Opiant Pharmaceuticals
Mar 03, 2023
―
Uninformative Sell
1.08M
$0.00
Sierra Oncology
Jul 01, 2022
―
Uninformative Sell
742.50K
$0.00
Heron Therapeutics
Oct 21, 2024
CEO, Director
Uninformative Buy
24.28K
$513.98K
List of latest transactions for each holding click on a transaction to see Craig Collard's performance on stock
You May Also Like
Craig Collard insider profile FAQ
What is the percentage of profitable transactions made by Craig Collard?
The percentage of profitable transactions made by Craig Collard is 33%.
What is the average return per transaction made by Craig Collard?
The average return per transaction made by Craig Collard is -8.00%.
What stocks does Craig Collard hold?
Craig Collard holds: ~CRTX, OPNT, SRRA, HRTX stocks.
What was Craig Collard’s latest transaction?
Craig Collard latest transaction was an Uninformative Buy of $24.28K.
What was Craig Collard's most profitable transaction?
Craig Collard’s most profitable transaction was an Informative Buy of HRTX stock on November 17, 2023. The return on the trade was 63.30%.
What is Craig Collard's role in Cornerstone Therapeutics Inc?
Craig Collard's role in Cornerstone Therapeutics Inc is Chief Executive Officer, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.